Relentless innovation - Insights
Inspired by Mayo Clinic’s history of breaking down barriers to change medicine, we are constantly reimagining what’s possible in diagnostics.
Mayo Clinic has been recognized as the No. 1 gastroenterology and gastrointestinal surgery hospital in the nation by U.S. News & World Report every year since 1990. Backed by the experience and knowledge of more than 140 digestive disease...
Mayo Clinic Laboratories’ comprehensive menu of genetic cardiovascular testing provides results that support gene-based strategies to manage inherited cardiovascular disease.
New tests launched in March - Insights
In March 2023, Mayo Clinic Laboratories announced twenty nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in June - Insights
In June 2022, Mayo Clinic Laboratories announced forty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Against the odds: Alex Kraatz - Insights
As a two-time brain tumor survivor, Alex Kraatz has been through more harrowing medical experiences in his 34 years than most people face in a lifetime. But Alex’s fighting spirit, coupled with precision laboratory testing and cutting-edge...
New high-resolution urine drug testing profile - Insights
Bringing together advanced testing technology, unparalleled expertise, and a patient-focused approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol,...
Neurology Testing - Mayo Clinic Labs
Our laboratory collaborates closely with the practice and is designed to offer the most complex, clinically validated testing.
A decade-long search for answers ends at Mayo Clinic: Tyler Hart - Insights
After years of misdiagnosis, Tyler Hart found answers at Mayo Clinic, discovering he had NF155-IgG4 autoimmune nodopathy instead of CIDP